Hickory Point Bank & Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

Hickory Point Bank & Trust’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-750	Closed	-$16.1K	–	448
2026 Q1	$16.1K	Buy	+750	New	+$10.6K	0.01%	311

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hickory Point Bank & Trust's DAWN Position: Q2 2026 in Review

Hickory Point Bank & Trust sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 750 shares — an estimated $16.1K sold.

Hickory Point Bank & Trust first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $16.1K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Hickory Point Bank & Trust reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Hickory Point Bank & Trust sold 750 Day One Biopharmaceuticals shares in Q2 2026, an estimated $16.1K.
Hickory Point Bank & Trust first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Hickory Point Bank & Trust's Day One Biopharmaceuticals position peaked at $16.1K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Hickory Point Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.